LIR LIFE SCIENCES CORP

Read how LIR Life Sciences Corp. meets regulatory milestones with transparent filings, fueling investor confidence and positioning it as a leading critical‑metals player.

Phase 2 launch: LIR Life Sciences & Neuland Labs advance peptide‑design for next‑gen transdermal delivery, boosting non‑invasive therapeutics potential.